sandimmun neoral 25 mg capsule moi
novartis pharma ag - cyclosporinum - capsule moi - 25 mg
sandimmun neoral 50 mg capsule moi
novartis pharma ag - cyclosporinum - capsule moi - 50 mg
sandimmun neoral 100 mg capsule moi
novartis pharma ag - cyclosporinum - capsule moi - 100 mg
mezym forte 25000 extra 25000 ui/22500 ui/1250 ui capsule cu mini-comprimate gastrorezistente
berlin-chemie ag - pancreatinum - capsule cu mini-comprimate gastrorezistente - 25000 ui/22500 ui/1250 ui
mezym forte 10000 extra 10000 ui/9000 ui/500 ui capsule cu mini-comprimate gastrorezistente
berlin-chemie ag - pancreatinum - capsule cu mini-comprimate gastrorezistente - 10000 ui/9000 ui/500 ui
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologice - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
aminoplasmal 100 g l cu electroliti 100 g/l soluţie perfuzabilă
b. braun melsungen ag - combinaţie - soluţie perfuzabilă - 100 g/l
travatan picaturi oftalmice, solutie 40 mcg/ml
novartis pharma ag - travoprostum - picaturi oftalmice, solutie - 40 mcg/ml
lipofundin mct lct 10% emulsie perfuzabilă
b. braun melsungen ag - lipofundinum - emulsie perfuzabilă - 10%
lipofundin mct lct 20% emulsie perfuzabilă
b. braun melsungen ag - lipofundinum - emulsie perfuzabilă - 20%